A nasal spray technology that enables the delivery of psychedelic and non-psychedelic drugs to treat mental health disorders will enter development for clinical use following the signing of a licence agreement with startup company InnarisBio, an atai Life Sciences company. University of Queensland researcher Dr Harendra Parekh and his team developed the solution-to-gel intranasal drug delivery technology – […]
Read More… from Nasal spray tech to deliver psychedelic and non-psychedelic drugs